Facial Psoriasis Log-based Area and Severity Index: A valid and reliable severity measurement method detecting improvement of facial psoriasis in clinical practice settings

Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial

(2015) K. Papp et al.   BRITISH JOURNAL OF DERMATOLOGY

Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

(2015) Richard B. Warren et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Efficacy and safety of brodalumab in subpopulations of patients with difficult-to-treat moderate-to-severe plaque psoriasis

(2015) Kim Papp et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Facial Psoriasis log-based Area and Severity Index (fPLASI): construct validity of a new facial psoriasis measurement tool

(2011) H.H. Kwon et al.   BRITISH JOURNAL OF DERMATOLOGY

Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A?systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis

(2011) Amanda Robinson et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

High-concentration (20 μg g−1) tacalcitol ointment in the treatment of facial psoriasis: an 8-week open-label clinical trial

(2010) J.W. Choi et al.   BRITISH JOURNAL OF DERMATOLOGY

Methods of Outcomes Measurement in Nail Psoriasis

(2010) M. Augustin et al.   DERMATOLOGY

What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature

(2010) V Bronsard et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature

(2010) E Puzenat et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review

(2009) Phyllis I. Spuls et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Method of assessing involved facial areas: rule of fours

(2008) H-S. Yoon et al.   BRITISH JOURNAL OF DERMATOLOGY

A comparison between BSA, PASI, PLASI and SAPASI as measures of disease severity and improvement by therapy in patients with psoriasis

(2008) Tilo Henseler et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Classification of facial psoriasis based on the distributions of facial lesions

(2008) Seung Man Woo et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY